IL-8 Plasma Concentrations and the Risk of Future Coronary Artery Disease in Apparently Healthy Men and Women

Author:

Boekholdt S. Matthijs1,Peters Ron J. G.1,Hack C. Erik1,Day Nicholas E.1,Luben Robert1,Bingham Sheila A.1,Wareham Nicholas J.1,Reitsma Pieter H.1,Khaw Kay-Tee1

Affiliation:

1. From the Department of Cardiology (S.M.B., R.J.G.P.) and the Laboratory for Experimental Internal Medicine (P.H.R.), Academic Medical Center, Amsterdam, the Netherlands; the Department of Public Health and Primary Care (N.E.D., R.L., N.J.W., K.T.K.), Institute of Public Health, University of Cambridge, Cambridge, United Kingdom; the Medical Research Council Dunn Nutrition Unit (S.A.B.), Cambridge, United Kingdom; and the Sanquin Research at the Central Laboratory of the Blood Transfusion Service (C...

Abstract

Objective— To study the role of IL-8 in predicting future coronary artery disease (CAD) in apparently healthy men and women. Methods and Results— A nested case-control study was performed in the prospective EPIC-Norfolk population study. We measured baseline IL-8 concentrations among 785 apparently healthy individuals in whom fatal or nonfatal CAD developed during follow-up and 1570 matched controls. Baseline IL-8 concentrations were higher in cases than in matched controls (3.5 pg/mL versus 3.1 pg/mL, P =0.001). The risk of future CAD increased with increasing quartiles of IL-8 ( P linearity <0.0001). Among individuals in the highest IL-8 quartile, the unadjusted odds ratio for future CAD was 1.72 (95% CI, 1.34 to 2.21; P <0.0001). The odds ratio for future CAD was still significant after adjustment for traditional risk factors (OR, 1.58; 95%CI, 1.19 to 2.09; P =0.002) and after additional adjustment for C-reactive protein and white cell count (OR, 1.77; 95% CI, 1.21 to 2.60; P =0.001). Conclusions— We conclude that among apparently healthy men and women, elevated levels of IL-8 are associated with an increased risk of future CAD. These prospective data support a role for IL-8 in the development of CAD events.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine

Cited by 162 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3